Established in 2003, Laviana has been an innovator in API and intermediate synthesis and as a CDMO service provider. Our main services support process development and production conversion of innovative drugs from laboratory to commercialization, including process research & development, process optimization, pilot process and scale production for new drugs from preclinical study to market launch, research into solid oral formulations (tablets and capsules), and IND/NDA submission of developmental drugs.

Currently, we have: 

• An R&D Center in Tianjin

• A GMP production campus in Cangzhou

• A Commercial scale pharmaceutical intermediates production facility in Jiangsu

• 3 business centers in Beijing and Shanghai and several sites throughout Europe, 

Asia and North America.

As a technology-driven CDMO focusing on small molecule innovative drug development and manufacture services, we also provide extended downstream services. We are committed to building the world’s leading one-stop service platform for innovative process research and manufacture outsourcing (CDMO). Laviana Pharma will soon complete the construction of its commercial production base to achieve the layout of the whole process service capability of small molecule innovative drug development and manufacture.

(1) Insight into industry trends: We provide services targeting multi-species and small scale innovative drugs and participate in differentiated competition with our featured multi-functional production lines.

(2) Our CSO has over 10 years of work experience with Pfizer, BMS, DuPont Pharma and GSK; leading development for dozens of innovative drugs in medicinal chemistry, analytical chemistry, synthetic process and pilot magnification.

(3) Technology diversification: relying on our asymmetric synthesis technology, diversified reaction technology, continuous flow reaction technology, enzyme-catalyzed reaction technology, we have many methods and modalities to meet the needs of customers at different development stages. Thus reducing R&D and production costs, improve R&D, pilot test and focus production efficiency, optimizing cost and lower energy consumption at the product stage.

(4) Flexibility: All under GMP at the Cangzhou campus, our flexible and intelligent design production suites are customizable to suit every client’s project. From 1kg to 1000kg, equipment is allocated as needed for each synthesis, this includes our high potency/cytotoxic API manufacturing suite rated for OEL 5. Flexibility without compromise, all quality management systems align with ICH guidelines. 

(5) Customer satisfaction: Laviana has served more than 500 customers, and garnered wide acclaim from domestic and foreign innovative pharmaceutical companies. We continue to listen to our clients who have asked that we accumulate resources, tools and data systems that facilitate ongoing and real-time updates and communication.

Following the corporate philosophy of Customer Oriented, Science Driven, Continuous Innovation, Satisfying Customers and Pursuit of Excellence, Laviana Pharma is committed to providing innovative drug R&D outsourcing and striving to be a provider of high-quality chemical services for every pharmaceutical company.